Myriad Genetics, Inc.MYGNNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Latest
-180.85%
↑ 60% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-455.26%
Historical baseline
PeriodValue
2025-180.85%
202455.66%
2023-128.78%
2022-297.14%
202188.29%
2020-11.36%
2019-4390.26%
2018-96.69%
2017490.62%
2016-82.12%